Renaissance Technologies
NDRA icon

Renaissance Technologies’s ENDRA Life Sciences NDRA Stock Holding History

Renaissance Technologies’s Portfolio NDRA Stock Details NDRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$112K Buy
+18,764
New +$97.1K ﹤0.01% 2996
2023
Q4 		– Sell
-6
Closed -$11K – 3993
2023
Q3 		$11K Hold
6
– – ﹤0.01% 3577
2023
Q2 		$15K Buy
+6
New +$16.9K ﹤0.01% 3803
2022
Q4 		– Sell
-8
Closed -$86K – 4304
2022
Q3 		$86K Sell
8
-8
-50% -$82.6K ﹤0.01% 3640
2022
Q2 		$132K Buy
16
+6
+60% +$53.7K ﹤0.01% 3771
2022
Q1 		$136K Buy
10
+4
+67% +$71.7K ﹤0.01% 3736
2021
Q4 		$150K Buy
+6
New +$255K ﹤0.01% 3607
2021
Q1 		– Sell
-2
Closed -$65K – 3579
2020
Q4 		$65K Buy
+2
New +$53.4K ﹤0.01% 3303
2020
Q3 		– Sell
-1
Closed -$18K – 3574
2020
Q2 		$18K Buy
+1
New +$29K ﹤0.01% 3374

Other funds holding NDRA

ACM
Altium Capital Management New York $68.8M AUM 7.27% 1-Year Est. Return
Citizens Financial Group
Citizens Financial Group Providence, Rhode Island $8.58B AUM 20.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Renaissance Technologies's NDRA Position: Q3 2026 in Review

Renaissance Technologies opened a new position in ENDRA Life Sciences (NDRA) in Q3 2026: 18,764 shares worth $112K. The stake represents ﹤0.01% of the portfolio and ranks #2996 among its holdings. This is a return to the name: Renaissance Technologies previously reported a position in NDRA as recently as Q3 2023.

Renaissance Technologies first reported a position in NDRA in Q2 2020 and has held it in 9 quarters since. The position peaked at $150K in Q4 2021. 6 funds tracked by Wall St. Rank hold NDRA as of Q3 2026.

  • Renaissance Technologies held 18,764 shares of ENDRA Life Sciences worth $112K as of Q3 2026.
  • ENDRA Life Sciences was a new Renaissance Technologies position in Q3 2026.
  • ENDRA Life Sciences made up ﹤0.01% of Renaissance Technologies's portfolio in Q3 2026, its #2996 holding.
  • Renaissance Technologies first reported a position in ENDRA Life Sciences in Q2 2020 and has held it in 9 quarters since.
  • Renaissance Technologies's ENDRA Life Sciences position peaked at $150K in Q4 2021.
  • 6 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q3 2026.

Based on Renaissance Technologies's 13F filing for Q3 2026, filed 12 Nov 2026.